Aug 29 Watch 7:41 Did outcry on social media lead to Mylan’s generic EpiPen? By PBS News Hour After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New… Continue watching
Feb 10 Lower drug prices: Does any candidate have an Rx? By Philip Moeller The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office. Continue reading
Jul 06 At least 7 states limit patient costs for high-priced drugs By Michael Ollove, Stateline As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the financial pain for patients who need medicine that can cost up to hundreds of… Continue reading
May 12 High price tag puts Hepatitis-C cure out of reach for boomers on Medicare By Richard Knox, NPR A growing number of people who got infected in the 1960s through the 1990s have now "used up" the infection's latency period, notes Dr. Camilla Graham of Beth Israel Deaconess Hospital in Boston, "which is why we're now seeing this… Continue reading
Dec 17 Watch Should doctors be paid by pharmaceutical companies to promote their drugs? Should doctors be paid by pharmaceutical companies to promote their drugs?… Continue watching
Nov 09 Watch Maine’s prescription for drug savings: Go foreign Drug companies and the State of Maine battle over the importation of prescription drugs. Continue watching
Apr 12 Watch Coming Soon: China’s Health Care Reform NewsHour special correspondent Jeffrey Kaye reports on China's health care reform. Continue watching
Sep 01 Watch FDA’s Safety Role in Question After Egg Recall A massive egg recall over fears of a salmonella outbreak raises new questions on whether the Food and Drug Administration can handle its regulatory role. Betty Ann Bowser has more. Continue watching